Top 10 Companies in the (R)-3-amino-1-butanol (CAS No. 61477-40-5) Market (2026): Market Leaders Driving Chiral Innovation

MARKET INSIGHTS

Global (R)-3-amino-1-butanol (CAS No. 61477-40-5) market size was USD 18.6 million in 2025 and is projected to grow from USD 20.1 million in 2026 to USD 38.4 million by 2034, indicating a CAGR of 7.4% over the forecast period.

(R)-3-amino-1-butanol is a chiral amino alcohol featuring an (R)-configuration at the third carbon and the molecular formula C₄H₁₁NO. Its dual functional groups—amino and hydroxyl—enable versatile applications across fine and specialty chemicals, and it is a key building block for chiral intermediates in active pharmaceutical ingredient (API) synthesis.

Demand for enantiopure compounds in drug development, coupled with escalating investment in chiral chemistry and a broadening pharmaceutical pipeline, sustains market momentum. Advances in asymmetric synthesis technologies have expanded the compound’s utility for high‑purity intermediates, while core suppliers such as Sigma‑Aldrich (Merck KGaA), TCI Chemicals, and Alfa Aesar continue to supply industrial and research‑grade material worldwide.

(R)-3-amino-1-butanol (CAS No. 61477-40-5) Market – View in Detailed Research Report

Top 10 Companies in the (R)-3-amino-1-butanol (CAS No. 61477-40-5) Market

1️⃣ Merck KGaA

Headquarters: Darmstadt, Germany
Key Offering: Pharmaceutical‑grade (R)-3‑amino‑1‑butanol, custom synthesis services

Merck KGaA leverages its extensive GMP infrastructure to deliver high‑purity intermediates that meet stringent regulatory requirements. The company’s focus on scalable, continuous‑flow processes reduces batch variability and enhances throughput for API manufacturers.

Sustainability Initiatives:

• Investment in renewable feedstock sourcing
• Process intensification to lower energy consumption
• Partnerships with CDMOs to reduce carbon footprint

2️⃣ Tokyo Chemical Industry (TCI)

Headquarters: Tokyo, Japan
Key Offering: High‑purity chiral intermediates, enzymatic resolution kits

TCI’s advanced asymmetric catalysis platform delivers enantiomeric excesses above 99% with reduced catalyst loadings. The company’s global distribution network supports rapid supply to pharmaceutical R&D labs.

Sustainability Initiatives:

• Adoption of greener solvents and recyclable media
• Development of enzyme‑based processes with lower waste generation
• Collaboration with academic centers for green chemistry research

3️⃣ Biosynth AG

Headquarters: Basel, Switzerland
Key Offering: Fine‑chemical synthesis, custom chiral building blocks

Biosynth AG specializes in tailor‑made chiral syntheses for specialty pharmaceuticals and agrochemicals. Their proprietary chiral catalysts enable rapid scale‑up for niche intermediates.

Sustainability Initiatives:

• Implementation of continuous‑flow reactors to reduce solvent use
• Zero‑waste synthesis protocols
• ISO 14001‑certified manufacturing facilities

4️⃣ Santa Cruz Biotechnology (SCBT)

Headquarters: Dallas, USA
Key Offering: Research‑grade (R)-3‑amino‑1‑butanol, analytical services

SCBT supplies high‑purity material for academic and industrial research, supporting early‑stage drug discovery. Their quality assurance program aligns with global GMP standards.

Sustainability Initiatives:

• Use of bio‑derived solvents in synthesis
• Energy‑efficient purification steps
• Supplier engagement for sustainable raw material sourcing

5️⃣ Hairui Fine Chemicals

Headquarters: Guangzhou, China
Key Offering: Bulk production of (R)-3‑amino‑1‑butanol, cost‑effective intermediates

Hairui Fine Chemicals has expanded its production capacity through investment in chiral catalysis, positioning itself as a leading low‑cost supplier for generic drug manufacturers.

Sustainability Initiatives:

• Adoption of renewable energy in production plants
• Water recycling systems for downstream processing
• Compliance with China’s national green chemistry guidelines

6️⃣ Capot Chemical

Headquarters: Shanghai, China
Key Offering: Custom chiral synthesis, API intermediates

Capot Chemical focuses on delivering high‑purity intermediates for pharmaceutical companies, leveraging its in‑house enzymatic resolution expertise.

Sustainability Initiatives:

• Implementation of closed‑loop solvent recovery
• Use of biodegradable catalysts
• Collaboration with local universities for green chemistry development

7️⃣ Combi-Blocks Inc.

Headquarters: New York, USA
Key Offering: Modular synthesis platforms for chiral compounds

Combi-Blocks offers flexible, modular synthesis solutions that enable rapid prototyping of chiral intermediates, catering to R&D and small‑batch production needs.

Sustainability Initiatives:

• Modular design reduces waste and energy use
• Integration of biocatalytic steps for greener pathways
• Partnerships with sustainability‑focused investors

8️⃣ Oakwood Products

Headquarters: Portland, USA
Key Offering: High‑purity chiral intermediates, analytical support

Oakwood Products supplies both raw intermediates and analytical services, ensuring consistency across production batches for pharmaceutical manufacturers.

Sustainability Initiatives:

• Adoption of green chemistry principles in all processes
• Carbon‑neutral facility operations target by 2035
• Employee training on sustainability best practices

9️⃣ Apollo Scientific

Headquarters: London, UK
Key Offering: Specialty chiral intermediates, custom synthesis

Apollo Scientific specializes in niche chiral intermediates for emerging therapeutic areas, maintaining high standards of purity and compliance.

Sustainability Initiatives:

• Investment in renewable energy for production
• Zero‑waste policy for all manufacturing lines
• Collaboration with NGOs to promote sustainable chemistry education

🔟 AAblocks LLC

Headquarters: San Francisco, USA
Key Offering: Custom chiral building blocks, rapid synthesis

AAblocks provides rapid, scalable synthesis of chiral intermediates for biotech and pharma, focusing on flexibility and speed.

Sustainability Initiatives:

• Implementation of continuous‑flow technologies to cut solvent usage
• Use of bio‑derived reagents where possible
• Transparent reporting of environmental metrics

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/307563/aminobutanol-market

Get Full Report: https://www.24chemicalresearch.com/reports/307563/aminobutanol-market

Outlook

Global demand for chiral intermediates is set to rise as pharmaceutical companies pursue enantiomerically pure drugs to improve safety and efficacy. The market will benefit from continued investment in asymmetric synthesis, coupled with an expanding pipeline of novel therapeutics. Supply chain resilience will remain a priority, prompting firms to diversify production sites and strengthen relationships with raw material suppliers.

Future Trends

• Biocatalytic and flow‑chemistry platforms will reduce production costs and environmental impact.
• Custom synthesis services will grow as small‑batch, high‑purity API production gains traction.
• Regulatory emphasis on sustainability will drive adoption of greener solvents and renewable feedstocks.
• Emerging markets in Asia‑Pacific will continue to expand production capacity, increasing regional supply.